Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.

Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K, Nnawa J, Kgwaadira BT, Bewlay L, Chebani T, Iketleng T, Mogashoa T, Makhema J, Musonda RM, Essex M, Kasvosve I, Gaseitsiwe S.

AIDS. 2019 Dec 1;33(15):2415-2422. doi: 10.1097/QAD.0000000000002363.

PMID:
31764106
2.

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.

Seatla KK, Choga WT, Mogwele M, Diphoko T, Maruapula D, Mupfumi L, Musonda RM, Rowley CF, Avalos A, Kasvosve I, Moyo S, Gaseitsiwe S.

PLoS One. 2019 Nov 21;14(11):e0224292. doi: 10.1371/journal.pone.0224292. eCollection 2019.

3.

Hyperuricaemia is associated with dyslipidemia but not HbA1c among type 2 diabetes mellitus patients in Botswana.

Gobusamang E, Nyepetsi NG, Motswaledi MS, Kasvosve I.

Afr J Lab Med. 2019 Nov 7;8(1):786. doi: 10.4102/ajlm.v8i1.786. eCollection 2019.

4.

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.

Mogashoa T, Melamu P, Derendinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, Mokomane M, Kgwaadira B, Rankgoane-Pono G, Tsholofelo TT, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

Pathogens. 2019 Oct 28;8(4). pii: E208. doi: 10.3390/pathogens8040208.

5.

Potential role of Lu/BCAM in HIV-related atherosclerosis.

Motswaledi MS, Kasvosve I, Oguntibeju OO.

Afr J Lab Med. 2019 Sep 30;8(1):792. doi: 10.4102/ajlm.v8i1.792. eCollection 2019.

6.

Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.

Tawe L, MacDuffie E, Narasimhamurthy M, Wang Q, Gaseitsiwe S, Moyo S, Kasvosve I, Shin SS, Zetola NM, Paganotti GM, Grover S.

Int J Cancer. 2019 Jul 20. doi: 10.1002/ijc.32581. [Epub ahead of print]

PMID:
31325316
7.

Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana.

Mogashoa T, Melamu P, Ley SD, Streicher EM, Iketleng T, Kelentse N, Mupfumi L, Mokomane M, Kgwaadira B, Novitsky V, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

PLoS One. 2019 May 7;14(5):e0216306. doi: 10.1371/journal.pone.0216306. eCollection 2019.

8.

The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa.

Mboowa G, Mwesigwa S, Katagirya E, Retshabile G, Mlotshwa BC, Williams L, Kekitiinwa A, Kateete D, Wampande E, Wayengera M, Kintu BN, Kisitu GP, Kyobe S, Brown CW, Hanchard NA, Mardon G, Joloba M, Anabwani G, Pettitt E, Tsimako-Johnstone M, Kasvosve I, Maplanka K, Mpoloka SW, Hlatshwayo M, Matshaba M.

AAS Open Res. 2018 Apr 18;1:3. doi: 10.12688/aasopenres.12832.1.

9.

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay.

Rantshabeng P, Kasvosve I, Ndlovu A, Gaseitsiwe S, Moyo S.

PLoS One. 2019 Jan 30;14(1):e0211260. doi: 10.1371/journal.pone.0211260. eCollection 2019.

10.

Molecular characterization of hepatitis B virus in blood donors in Botswana.

Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S.

Virus Genes. 2019 Feb;55(1):33-42. doi: 10.1007/s11262-018-1610-z. Epub 2018 Oct 31.

PMID:
30382563
11.

Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers in Clinical Samples from Botswana.

Tawe L, Menegon M, Ramatlho P, Muthoga CW, Mutukwa N, Vurayai M, Bothudile W, Motshoge T, L'Episcopia M, Mosweunyane T, Kasvosve I, Severini C, Paganotti GM.

Am J Trop Med Hyg. 2018 Dec;99(6):1499-1503. doi: 10.4269/ajtmh.18-0440.

12.

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR.

Tawe L, Grover S, Narasimhamurthy M, Moyo S, Gaseitsiwe S, Kasvosve I, Paganotti GM.

MethodsX. 2018 May 31;5:569-578. doi: 10.1016/j.mex.2018.05.018. eCollection 2018.

13.

Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana.

Seatla KK, Avalos A, Moyo S, Mine M, Diphoko T, Mosepele M, Gaolatlhe T, Rowley CF, Ramaabya D, Jarvis JN, Kasvosve I, Gaseitsiwe S.

AIDS. 2018 Aug 24;32(13):1899-1902. doi: 10.1097/QAD.0000000000001920.

14.

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jun 1;13(6):e0198711. doi: 10.1371/journal.pone.0198711. eCollection 2018.

15.

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.

Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, Lockman S, Gaseitsiwe S.

Genes (Basel). 2018 May 17;9(5). pii: E259. doi: 10.3390/genes9050259.

16.

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):667-671. doi: 10.1089/AID.2017.0135. Epub 2018 Jun 12.

17.

Whole-Exome Sequencing Reveals Uncaptured Variation and Distinct Ancestry in the Southern African Population of Botswana.

Retshabile G, Mlotshwa BC, Williams L, Mwesigwa S, Mboowa G, Huang Z, Rustagi N, Swaminathan S, Katagirya E, Kyobe S, Wayengera M, Kisitu GP, Kateete DP, Wampande EM, Maplanka K, Kasvosve I, Pettitt ED, Matshaba M, Nsangi B, Marape M, Tsimako-Johnstone M, Brown CW, Yu F, Kekitiinwa A, Joloba M, Mpoloka SW, Mardon G, Anabwani G, Hanchard NA; Collaborative African Genomics Network (CAfGEN) of the H3Africa Consortium.

Am J Hum Genet. 2018 May 3;102(5):731-743. doi: 10.1016/j.ajhg.2018.03.010. Epub 2018 Apr 26.

18.

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jan 31;13(1):e0192030. doi: 10.1371/journal.pone.0192030. eCollection 2018. Erratum in: PLoS One. 2018 Jun 1;13(6):e0198711.

19.

The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management.

Mokomane M, Kasvosve I, de Melo E, Pernica JM, Goldfarb DM.

Ther Adv Infect Dis. 2018 Jan;5(1):29-43. doi: 10.1177/2049936117744429. Epub 2017 Dec 7. Review.

20.

Evaluation of the Influence of Gastrointestinal Coinfections on Rotavirus Vaccine Effectiveness in Botswana.

Mokomane M, Tate JE, Steenhoff AP, Esona MD, Bowen MD, Lechiile K, Pernica JM, Kasvosve I, Parashar UD, Goldfarb DM.

Pediatr Infect Dis J. 2018 Mar;37(3):e58-e62. doi: 10.1097/INF.0000000000001828.

Supplemental Content

Loading ...
Support Center